Royalty Pharma plc Annual Interest Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Royalty Pharma plc quarterly/annual Interest Expense history and growth rate from 2018 to 2023.
  • Royalty Pharma plc Interest Expense for the quarter ending March 31, 2024 was $44.2M, a 5.79% decline year-over-year.
  • Royalty Pharma plc Interest Expense for the twelve months ending March 31, 2024 was $184M, a 1.8% decline year-over-year.
  • Royalty Pharma plc annual Interest Expense for 2023 was $187M, a 0.41% decline from 2022.
  • Royalty Pharma plc annual Interest Expense for 2022 was $188M, a 13.1% increase from 2021.
  • Royalty Pharma plc annual Interest Expense for 2021 was $166M, a 5.78% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $187M -$774K -0.41% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $188M +$21.8M +13.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $166M +$9.08M +5.78% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $157M -$112M -41.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-15
2019 $269M -$11.4M -4.07% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $280M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.